Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data CXJ GROUP CO., Ltd files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2021
FY2021
FY2022
FY2023
FY2024
FY2025
FY2026
Revenue
0.8
1.05
2.77
2.13
2.32
0.46
0.53
Cost of revenue
0.61
0.4
1.04
0.95
0.67
0.09
0.18
Gross profit
0.19
0.65
1.73
1.18
1.65
0.37
0.36
Research and development
0.08
Selling and marketing
0.53
0.37
0.76
0.73
0.47
0.2
0.25
General and administrative
0.35
1.85
1.5
1.51
3.32
2.43
0.41
Operating expenses
3.79
2.62
0.66
Operating income
-0.68
-1.57
-0.5
-1.05
-2.13
-2.25
-0
Other non-operating income
-0
0.03
0.01
0.01
-0
0.3
Pre-tax income
-0.68
-1.57
-0.5
-1.05
-2.13
-2.25
-0
Income tax
0
0.01
0
0.01
0.01
0.03
0.01
Net income to minority interests
0.04
-0
-0
Net income
-0.72
-1.58
-0.54
-1.06
-2.14
-2.28
-0.01
EBITDA
-0.5
-1.05
-2.13
-2.25
0
EPS, basic
-0.01
-0.02
0.00
-0.01
-0.02
-0.02
0.00
EPS, diluted
-0.01
-0.02
0.00
-0.01
-0.02
-0.02
0.00
Shares, basic (weighted)
101
101
101
102
102
102
102
Shares, diluted (weighted)
101
101
101
102
102
102
102
Balance sheet
FY2021
FY2021
FY2022
FY2023
FY2024
FY2025
FY2026
Cash and equivalents
0.34
0.34
0.83
0.66
0
0.01
0.07
Receivables
0.44
0.01
0.06
0.06
0.06
0
0
Inventory
0.12
0.08
0.43
0.13
0.06
0.07
0.04
Other current assets
0.11
0.12
0.33
0.04
0.53
0.27
0.22
Total current assets
3.26
0.59
1.66
1.42
0.54
0.28
0.29
Property, plant and equipment
0
0
0
0
0
0
Lease right-of-use assets
0.19
0.09
0.08
0.03
0.07
0.01
0.03
Goodwill
4.76
4.44
3.43
2.79
1.74
Intangible assets
0.03
0
1.31
Other non-current assets
1.82
0.02
0.03
Total assets
3.49
5.12
5.17
5.56
2.36
0.3
0.33
Accounts payable
0.16
0.23
0.21
0.3
0.08
0.07
0.05
Accrued liabilities
0.07
0.06
0.12
0.32
0.53
0.63
0.23
Deferred revenue
2.19
2.04
2.49
1.91
0.61
0.6
1.07
Short-term debt
0.02
Total current liabilities
4
2.7
3.21
3.04
1.98
1.86
1.94
Lease liabilities
0.11
0.04
0.02
0
0.01
0.01
Other non-current liabilities
0.01
0.01
Total liabilities
4.11
2.74
3.24
3.05
1.99
1.86
1.95
Paid-in capital
4.03
4.03
5.59
5.59
5.96
5.96
Retained earnings
-0.74
-1.63
-2.17
-3.23
-5.36
-7.65
-7.66
Other comprehensive income
0.01
-0.13
-0.06
0.03
0.04
0.03
-0.03
Shareholders' equity
-0.63
2.38
1.9
2.49
0.36
-1.56
-1.62
Minority interests
0.03
0.03
Total equity
4.1
2.38
1.93
2.52
0.36
-1.56
-1.62
Total liabilities and equity
3.49
5.12
5.17
5.56
2.36
0.3
0.33
Shares outstanding
101
101
101
102
102
102
102
Cash flow statement
FY2021
FY2021
FY2022
FY2023
FY2024
FY2025
FY2026
Net income
-0.72
-1.58
-0.5
-1.06
-2.14
-2.28
-0.01
Depreciation and amortization
0
0
0
0
0
Deferred income tax
0.04
Change in receivables
-0.44
0.07
-0.05
-0.01
-0
0.06
-0
Change in inventory
-0.12
0.06
-0.37
0.29
0.02
-0.01
0.02
Change in payables
0.17
0.06
-0.01
0.1
-0.21
-0.01
-0.02
Cash from operations
0.09
0.1
0.44
-0.38
-0.59
-0.42
0.08
Capital expenditures
-0
-0
-0
Acquisitions
0.03
0
Cash from investing
-0.03
-0.01
0
-1.45
-0.01
Stock issued
1.59
0.37
Cash from financing
-0.05
0.22
0.08
1.71
-0.06
0.42
-0.02
Net change in cash
0.02
0.32
0.49
-0.17
-0.66
0.01
0.06
Free cash flow
0.44
-0.38
-0.59
Income taxes paid
0.03
Key metrics
Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $1.30 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
67.0%
Gross profit / revenue.
Operating margin
-0.1%
Operating income / revenue.
EBITDA margin
0.1%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-0.1%
Pre-tax income / revenue.
Net margin
-1.8%
Net income / revenue.
Operating cash flow margin
14.4%
Cash from operations / revenue.
Return on assets (ROA)
-3.1%
Net income / average total assets.
D&A / revenue
0.3%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
15.9%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-37.0%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
-12.7%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
-4.4%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
-32.9%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y
-11.2%
Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y
-5.8%
Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
8.8%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-61.1%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
-42.3%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
0.1%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
0.2%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
0.2%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.15x
Current assets / current liabilities.
Quick ratio
0.04x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.04x
(Cash + short-term investments) / current liabilities.
Days inventory + days sales outstanding - days payables.
Per share
Metric
Value
How it is calculated
EPS, diluted
$0.00
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic
$0.00
Net income per basic share, as reported (split-adjusted).
Revenue per share
$0.01
Revenue / diluted weighted shares.
Operating cash flow per share
$0.00
Cash from operations / diluted weighted shares.
Book value per share
-$0.02
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
250x
Market cap / revenue.
P/OCF
1,738x
Market cap / cash from operations, when positive.
EV/Sales
250x
Enterprise value / revenue.
EV/EBITDA
171,901x
Enterprise value / EBITDA, when both are positive.
Earnings yield
-0.0%
Net income / market cap (the inverse of P/E).
What was CXJ GROUP CO., Ltd's revenue in fiscal 2026?
CXJ GROUP CO., Ltd reported revenue of $531.6K for fiscal 2026, 15.9% higher than the year before.
Was CXJ GROUP CO., Ltd profitable in fiscal 2026?
No. It reported a net loss of $9.7K.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.